Terms: = Breast cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
76 results:
1. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
Sahraoui G; Rahoui N; Driss M; Mrad K
Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
[TBL] [Abstract] [Full Text] [Related]
2. Updates in the Use of Immunohistochemical Stains in breast and Gynecologic Pathology.
Jenkins TM; Mehr CR
Arch Pathol Lab Med; 2024 Jan; 148(1):33-47. PubMed ID: 37406290
[TBL] [Abstract] [Full Text] [Related]
3. Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with breast cancer.
Lan A; Chen J; Li C; Jin Y; Wu Y; Dai Y; Jiang L; Li H; Peng Y; Liu S
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674372
[TBL] [Abstract] [Full Text] [Related]
4. Incidence of Occult breast cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
Wong SM; Ferroum A; Apostolova C; Alhassan B; Prakash I; Basik M; Boileau JF; Meterissian S; Aleynikova O; Wong N; Foulkes WD
Ann Surg Oncol; 2022 Oct; 29(11):6660-6668. PubMed ID: 35616744
[TBL] [Abstract] [Full Text] [Related]
5. Relationships of
Sengoz T; Karakaya YA; Gultekin A; Yaylali O; Senol H; Yuksel D
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):32-38. PubMed ID: 34991834
[TBL] [Abstract] [Full Text] [Related]
6. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion.
Gao YH; Qu SS; Cao LQ; Yao M
Neoplasma; 2022 Mar; 69(2):274-282. PubMed ID: 34846157
[TBL] [Abstract] [Full Text] [Related]
7. [What's new in the management of endometrial cancer? Update on the new European recommendations for 2021].
Azaïs H; Lecointre L; Canlorbe G;
Gynecol Obstet Fertil Senol; 2021 Sep; 49(9):691-697. PubMed ID: 33757927
[TBL] [Abstract] [Full Text] [Related]
8. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of the radio-pathological factors of triple negative breast cancer and determination of risk profiles.
Sebastián Sebastián C; García Mur C; Gros Bañeres B; Cruz Ciria S; Rosero Cuesta DS; Suñén Amador I
Radiologia (Engl Ed); 2020; 62(5):365-375. PubMed ID: 32093905
[TBL] [Abstract] [Full Text] [Related]
10. Correlation analysis of 18F-FDG PET/CT for the staging and treatment effect assessment of breast cancer.
Li Y; Dai Y; Guo Y; Wang J; Duan X
J Xray Sci Technol; 2019; 27(6):1131-1144. PubMed ID: 31561405
[TBL] [Abstract] [Full Text] [Related]
11. Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
Pare R; Soon PS; Shah A; Lee CS
PLoS One; 2019; 14(4):e0214604. PubMed ID: 30998679
[TBL] [Abstract] [Full Text] [Related]
12. Immunophenotyping of male breast cancer - Experience at a tertiary care centre.
Pasricha S; Kamboj M; Tanwar P; Gupta G; Panigrahi M; Sharma A; Durga G; Mehta A
Indian J Pathol Microbiol; 2019; 62(2):226-231. PubMed ID: 30971545
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer.
Acar E; Turgut B; Yiğit S; Kaya G
Nucl Med Commun; 2019 Jul; 40(7):764-772. PubMed ID: 30925542
[TBL] [Abstract] [Full Text] [Related]
14. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.
Aljabery F; Shabo I; Gimm O; Jahnson S; Olsson H
Urol Oncol; 2018 Dec; 36(12):530.e7-530.e18. PubMed ID: 30539751
[TBL] [Abstract] [Full Text] [Related]
15. breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract] [Full Text] [Related]
16. Protein expressions of AIB1, p53 and Bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis.
Liang M; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5134-5139. PubMed ID: 30178833
[TBL] [Abstract] [Full Text] [Related]
17. [Histological and molecular classification of endometrial carcinoma and therapeutical implications].
Genestie C; Leary A; Devouassoux M; Auguste A
Bull Cancer; 2017 Dec; 104(12):1001-1012. PubMed ID: 29031505
[TBL] [Abstract] [Full Text] [Related]
18. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract] [Full Text] [Related]
19. Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients.
Ding L; Zhang Z; Xu Y; Zhang Y
Bioengineered; 2017 Jul; 8(4):383-392. PubMed ID: 28075663
[TBL] [Abstract] [Full Text] [Related]
20. Imaging and histologic prognostic factors in triple-negative breast cancer and carcinoma in situ as a prognostic factor.
Sebastián Sebastián C; García Mur C; Cruz Ciria S; Rosero Cuesta DS; Gros Bañeres B
Radiologia; 2016; 58(4):283-93. PubMed ID: 27064084
[TBL] [Abstract] [Full Text] [Related]
[Next]
